---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-029592"
form_type: "8-K"
ticker: "RMTI"
cik: "0001041024"
company_name: "ROCKWELL MEDICAL, INC."
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T19:16:12.110901+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Rockwell Medical posts record Q3 revenue of $18.7M; cuts debt to $10M; targets 2024 profitability

## Summary
- Q3 revenue $18.7M (+16.9% YoY), highest quarterly revenue; FY2022 guidance $65-70M.
- Cash used in ops $1.1M (down 81% QoQ); cash balance $27.6M, adjusted $22.6M after debt prepayment.
- Reduced long-term debt from $15M to $10M via $5M prepayment; 10-month interest-only period starts Dec 2022.
- Reacquired distribution rights from Baxter, adding 700+ hemodialysis customers; targets $100M annual revenue.
- Discontinued US NDAs for TRIFERIC (saves $2-3M/yr); paused FPC Home Infusion; workforce reductions.

## SEC filing metadata
- accession: 0001628280-22-029592
- form_type: 8-K
- ticker: RMTI
- cik: 0001041024
- company_name: ROCKWELL MEDICAL, INC.
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1041024/000162828022029592/0001628280-22-029592-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1041024/000162828022029592/rmti-20221114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-029592
- JSON: https://secwatch.observer/filing/0001628280-22-029592.json
- Plain text: https://secwatch.observer/filing/0001628280-22-029592.txt

## Key facts
- Earnings Releases
  ROCKWELL MEDICAL, INC. reported third quarter ended September 30, 2022 results: revenue $18.7 million.
  - Period: third quarter ended September 30, 2022
  - Revenue: $18.7 million
  - Result: reported results
  source text: Revenue for the three months ended September 30, 2022 was $18.7 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1041024/000162828022029592/0001628280-22-029592-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.